Please login to the form below
symptoms
This page shows the latest symptoms news and features for those working in and with pharma, biotech and healthcare.
Novartis gains EU approval for relapsing MS drug Kesimpta
When myelin is damaged, nerve conduction can slow down or stop completely, leading to the neurologic signs and symptoms associated with MS.
Latest news
-
Lilly, Vir and GSK’s antibodies reduce viral load by 70% in low-risk COVID-19 patients
arm visiting an accident &emergency department for COVID-19-related symptoms.
-
Oxford University to investigate nasal spray delivery of AZ-partnered COVID-19 vaccine
Participants will be asked to fill in an electronic diary card to inform study investigators of any symptoms following vaccination.
-
J&J’s multiple sclerosis therapy Ponvory moves closer to EU approval
When myelin is damaged, nerve conduction can slow down or stop completely, leading to the neurologic signs and symptoms associated with MS. ... Relapsing forms of multiple sclerosis have varied and often unpredictable symptoms, posing a unique human,
-
Roche, Regeneron’s COVID-19 antibody cocktail cuts hospitalisation or death by 70%
The antibody cocktail also met all key secondary endpoints in the REGN-COV 2067 trial, including the ability to reduce symptom duration by a median of four days.
-
J&J’s MS drug ponesimod receives approval in the US
Every person with multiple sclerosis is affected differently, given variability in both the underlying disease and emerging symptoms.
More from news
Approximately 2 fully matching, plus 1,231 partially matching documents found.
Latest Intelligence
-
New thinking, bold action: building a better future for people living with severe diseases
The goal is to build an AI model using patient data to help predict symptom and pattern flares.
-
Helping patients to help themselves – how pharma can get more from patient support programmes
While for established patients, practical support on managing the physical symptoms became the focus.Once the needs are understood then relevant solutions can be developed.
-
The search for effective drug treatments for COVID-19
Diseases’ (NIAID) placebo-controlled phase 3 study in patients with moderate to severe symptoms of COVID-19, including those who were critically ill, and Gilead’s global phase 3 study (SIMPLE
-
2021: the year of decentralisation in drug development
Additionally, participants can be continuously monitored using wearables, electronic diaries and telemedicine, allowing sites to respond in real time and engage directly with patients more often, even identifying early symptoms that ... Identifying the
-
Power to the patient: digital innovation supporting patients with chronic diseases
In HS Online’s case, this intent is indicated by completion of a symptom checker tool and downloading the results, and where local regulations allow, giving patients direct access to an ... A sophisticated, always-on measurement tool, such as a digital
More from intelligence
Approximately 0 fully matching, plus 130 partially matching documents found.
Latest appointments
-
Srdjan Stankovic joins Acadia Pharmaceuticals
in developing groundbreaking medicines to treat debilitating symptoms associated with these diseases.
-
Bayer's Kirstyn Nicholas joins Spirit Healthcare
Nicholas has previously specialised in the provision of medical devices designed to help manage screening, symptoms and treatment.
-
Ex-Bayer R&D chief joins Gemmus Pharma board
San Francisco-based Gemmus was founded in 2007 and is developing a drug that decreases the severity of flu symptoms by modulating the release of pro-inflammatory cytokines.
More from appointments
Approximately 0 fully matching, plus 3 partially matching documents found.
Latest from PMHub
-
Why it’s in everyone’s interest the Women’s Health Strategy for England succeeds
4. Menopausal women are now the fastest growing demographic in the workplace yet one in four considers leaving work due to the symptoms. ... The mother who is alive to look after her child. The woman who survives because they caught her cancer early
-
Next Generation Consultancy Launches To Help Creative Agency Teams Manage The Pressures Of Agency Life
1, 2. According to a 2020 CIPR survey, one fifth of communications professionals experience mental health issues, and more than half of those said work pressure contributed to their symptoms, with
-
How to make sure your adverts for clinical trials are compliant
Click here to find out who can take part. Take part in this clinical trial for a new migraine treatment that eases the symptoms of migraines.
-
fox&cat
According to a 2020 CIPR survey, one fifth of communications professionals experience mental health issues, and more than half of those said work pressure contributed to their symptoms, with unrealistic deadlines
-
Porphyria Awareness Week – Round Up
Symptoms are broad and can vary dramatically in severity, often leaving doctors mystified whilst patients suffer.
More from PMHub
Approximately 0 fully matching, plus 146 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- Freelance Account Manager - Creative Healthcare Comms - Immediat...
-
Excellent Day Rate
- Freelance Medical Writer - Creative Healthcare Comms - 2 month t...
-
Excellent Day Rate
- Senior Account / Programme Manager - MedComms - Buckinghamshire
-
Highly Competitive Remuneration packages
- FREELANCE Medical Writer, Senior Medical Writer, Principal Medic...
-
Highly Competitive Day Rate, Bonus &Benefits
- Senior Content Editor - Biotechnology
-
Salary TBC
- Senior Leadership Role – Medical Communications – North West
-
Highly Competitive Salary, Bonus &Benefits
-
Account Management
-
Competitive Salary Offered
-
Principal Medical Writer
-
Varies on experience
- CureVac expands COVID-19 vaccine trial protocol to include variant specification
- Pfizer helps fund biotech venture from former researchers at closed Kent facility
- Bayer’s finerenone scores FDA priority review for chronic kidney disease
- J&J looks ahead at potential flu therapy after approval of its COVID-19 vaccine
- Merck & Co, Ridgeback Biotherapeutics’ COVID-19 drug shows early promise
- Moderna launches COVID-19 vaccine booster study to address new variants
- Live Webinar: Nanobiotechnology, Artificial Intelligence, and Virtual Care
- Opdivo improves survival in oesophageal cancer
- Keytruda shows significant and meaningfully improvement in kidney cancer
- Congress 2020 BC (before COVID-19)
- Shaping the Future of Medicine, Science, and Technology
- Live Webinar: Virtual Trials, Remote Care, & Cross-Border Collaboration: Ethical & Legal Challenges
PMHub
Langland
Langland, a Publicis Health company, is the only health communications agency that thinks further across Clinical Trial Experience, Medical Strategy...
Latest intelligence
- Virtual congresses: video thrilled the cardio tsar
- Chris Ross explores the key learnings from a year of virtual congresses...
- When Will We Be Back To Normal?
- The definitive question of 2021, whether you’re a homeschooling parent, a homebound professional, a wanderer with nowhere to go… or all three at once....
- How to tell your healthcare story.
- Healthcare research is not a simple story and the people in charge of those moments need to be careful about the story that they tell....
Quick links
Infographics
